What is Gynesonics about? How are you changing the standard of care in uterine fibroids? Gynesonics is focused on advancing women’s health by developing uterus-preserving, incision free, transcervical technology. Currently, we are focused on the treatment of symptomatic uterine fibroids, a condition that affects up to 50% of women [...]
The medtech specialisation of VC Geneva Endeavour Vision, among the leading Europeans, is reinforced with the launch of a new fund dedicated end 2018. Interview with Damien Tappy, president and co-founder. La stratégie d’Endeavour Vision, capital-risqueur genevois parmi les leaders européens spécialisés dans les technologies médicales (medtech), se renforce [...]
Endeavour Vision launched Europe's largest medical technology fund (medtech) in 2016 from Geneva. A second should follow in the coming months. An interview with its president and co-founder, Damien Tappy. Endeavour Vision a lancé le plus gros fonds européen dédié aux technologies médicales (medtech) en 2016 depuis Genève. Un [...]
Endeavour Vision invested in Medartis. Located in Basel, Switzerland, the company develops, manufactures and distributes medical internal fixation devices and surgical instruments offered in system solutions for small bone fractures focusing on the extremities. Medartis was founded in 1997 by Dr. Thomas Straumann. The company launched its first products [...]
Endeavour Medtech Growth (EMG) Fund final close at EUR 250m (USD 275m) EMG is the largest fund in Europe dedicated to medtech Fund oversubscribed – significantly exceeds EUR 150m target Fund to allocate between EUR 10m and EUR 20m per investment St Peter Port, Guernsey – 22 March 2016 [...]